Becker's Healthcare October 6, 2023
Noah Schwartz

The Drug Enforcement Administration extended certain COVID-19 era rules to allow healthcare providers to continue prescribing certain controlled substances via telehealth through the end of 2024, The Hill reported Oct. 6.

Controlled substances covered by the rule include stimulant medicines for attention-deficit/hyperactivity disorder, anxiety medications and medications for opioid use disorder. The extension is designed to give time to patients who have...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Digital Health, Govt Agencies, HHS, Patient / Consumer, Provider, Technology, Telehealth
Related Articles:
Teladoc expands virtual sitter capabilities
AHA, others urge Congress to act on alternative payment models, avoid physician payment cut
Are telehealth visits for pediatric primary care associated with higher rates of health care utilization?
Hospital recovery at risk if Congress doesn’t extend telehealth, Fitch Ratings says
End of home health, telehealth coverage threatens hospitals' recovery: Fitch

Share This Article